T. Gendugov

T. Gendugov

Auto-generated profile, based on publicly available information

T. Gendugov

Volgograd State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2020 in Bulletin of Science and Practice
Verified
Journal Article
Open access
TGT. Gendugov
T. Gendugov
AGA. Glushko
A. Glushko
ACA. Chiriapkin
A. Chiriapkin
VCV. Chiriapkin
V. Chiriapkin
The article considers the study in silico of the affinity of 3-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-4(3H)-quinazolinone (VMA-10-21 compound) to the benzodiazepine binding site of the GABA А receptor by molecular docking method. The computational experiment was carried out using a set of Autodock programs. As a result, the method for predicting the affinity of the simulated compounds to the benzodiazepine binding site of the GABA A receptor was developed. The highest correlation coefficient between the pKi value and the average docking energy in the benzodiazepine binding site (0.54) was obtained using a set of amino acids Tyr 58 and Tyr 159. The predicted Ki value of the VMA-10-21 compound is 2.864 nM, which suggests a high affinity of the studied compound to this receptor.

15 May 2019 in Bulletin of Science and Practice
Verified
Journal Article
Open access
ACA. Chiriapkin
A. Chiriapkin
AGA. Glushko
A. Glushko
VCV. Chiriapkin
V. Chiriapkin
TGT. Gendugov
T. Gendugov
Computer simulation is a rapidly developing method of scientific researches. Currently, computational experiments are being conducted in various fields of human activity, including medical and pharmaceutical. This article discusses the latest achievements and scientific approaches of computer modeling of the cell wall, as well as three-dimensional reliable cell system that will help scientists to study cell processes. In particular, by developing such a computer model, scientists will be able to study the mechanisms of developing diseases and the action of drugs.

31 January 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
TGT. A. Gendugov
T. A. Gendugov
AGA. A. Glushko
A. A. Glushko
AOA. A. Ozerov
A. A. Ozerov
LSL. I. Shcherbakova
L. I. Shcherbakova
The aim of the research was to study the stability of a new pharmaceutical substance 3-[2-(4-phenyl-1-piperazino)-2-oxoethyl]quinazoline-4(3Н)-one under stress conditions.Materials and methods. The study was conducted in accordance with the recommendations of the ICH guidelines. The object of the study was a previously unknown derivative of quinazoline-4(3H)-one: 3-[2-(4-phenyl-1-piperazino)-2-oxoethyl] quinazoline-4(3Н)-one synthesized in Volgograd state medical university. The following laboratory equipment was used: HPLC chromatograph, HPLC-MS, centrifuge, electronic scales, pH meter, thermostat, laboratory filters. The computational experiment was conducted on a computer with an Intel Xeon E3-1230 processor using the programs ORCA 4.1. and GROMACS 2019.Results. The influence of the most unfavorable environmental factors, such as high temperature, light, oxidants, hydrolysis in acidic and alkaline environments, affect the stability of the test substance. The results of the computer-based stability prediction were confirmed by HPLC and HPLC-MS, and the degradation products of the substance under stressful conditions were determined. The conducted studies showed that the test substance is stable to UV radiation at the wavelength of 365 nm, at the elevated temperature (80°C), to the action of oxidants. But it is unstable to hydrolysis: in an alkaline medium of sodium hydroxide 1M, a break in the amide group occurs with the formation of 2-(4-oxoquinazoline-3-yl)acetic acid and 1-phenylpiperazine. And in an acidic environment, hydrochloric acid 1M is also destroyed, but it is significantly reduced, presumably due to the protonation and stabilization of tertiary nitrogen atoms in the molecule.Conclusion. The conducted research makes it possible to conclude that the test substance 3-[2-(4-phenyl-1-of piperazino)-2-oxoethyl]quinazoline-4(3Н)-one is stable to aggressive environmental factors, with the exception of hydrolysis in an alkaline environment that will be further considered in the preparation of regulatory documents for this pharmaceutical substance.